Back to companies

Palisade Bio Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Palisade Bio Inc (Palisade Bio) is a biopharmaceutical solutions provider. The company offers precision therapies for immune, inflammatory and fibrotic diseases. It also provides treatments for nervous system diseases. Palisade Bio offers solutions for treating conditions like ulcerative colitis and fibrostenotic Crohn's disease. The company’s products include PALI-2108 a microbiota-activated PDE4 inhibitor prodrug and PALI-1908. It offers its products to patients with moderate-to-severe inflammatory bowel diseases. Palisade Bio is headquartered in Danver, California, the US.

 Gain a 360-degree view of Palisade Bio Inc and make more informed decisions for your business Gain a 360-degree view of Palisade Bio Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 4600 South Syracuse Street, Suite 900, Danver, California, 80237
Website palisadebio.com
Telephone 1 858 7044900
No of Employees 14
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange PALI (NASD)
EPS XYZ
Net Income (2024) XYZ -16.2% (2024 vs 2023)
Market Cap* $362.8M
Net Profit Margin (2022) XYZ 0.0% (2024 vs 2023)
   
* As of and is in US$
View Palisade Bio Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Palisade Bio Inc premium industry data and analytics

30+

Clinical Trials

Determine Palisade Bio Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Palisade Bio Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Pipeline Drugs

Identify which of Palisade Bio Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

8

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Pipeline
PALI-2108: Ulcerative Colitis and Crohn’s Disease
Understand Palisade Bio Inc portfolio and identify potential areas for collaboration Understand Palisade Bio Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Palisade Bio Inc Emergent BioSolutions Inc Nature's Sunshine Products Inc Sage Therapeutics Inc Stemline Therapeutics Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Danver Gaithersburg Lehi Cambridge New York City
State/Province California Maryland Utah Massachusetts New York
No. of Employees 14 900 806 353 -
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Donald Williams Chairman Executive Board 2024 67
J.D. Finley Director; Chief Executive Officer; Chief Financial Officer Executive Board 2023 68
Mitch Jones, MD, Ph.D President; Chief Medical Officer Senior Management - -
Adarsh Patel Head - Chemistry, Manufacturing, and Controls Senior Management - -
Ryker Willie Senior Vice President-Finance Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Palisade Bio Inc key executives to enhance your sales strategy Gain insight into Palisade Bio Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?